(1 )Michallet M, Luporsi E, Soubeyran P, et al. BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study. BMC Cancer 2014; 14:503 (July 10, 2014); http://www.biomedcentral.com/1471-2407/14/503/abstract [http://www.biomedcentral.com/1471-2407/14/503/abstract]. (2) Haustein R, Millas C, Höer A, et al. Saving money in the European healthcare systems with biosimilars. Generics and Biosimilars Initiative Journal. 2012;1(3-4):120-6. (3) Soubeyran P, Kurtz JE, Michallet M, et al. Biosimilar epoetin for the management of chemotherapy-induced anaemia in elderly patients: a subanalysis of the ORHEO study. Presented at the MASCC 2014 Symposium, 26-28 June 2014. Abstract disponible en http://mascc2014.meetingxpert.net/mascc_595/poster_97015/pro... [http://mascc2014.meetingxpert.net/mascc_595/poster_97015/pro...] [last accessed 23rd July 2014].
CONTACTO: CONTACTO: Medios europeos: James Osborn / Tarnia Ross, +44 207627 0990 o Comunidad financiera: Karen King / Ruth Venning, +1224-212-2711
Sitio Web: http://www.hospira.com/
